Toggle navigation
Home
Search
Services
Blog
Contact
About
Human 3-Mea DNA Glycosylase and Alkylation Repair
Wyatt, Michael D.
Harvard University, Boston, MA, United States
Search 28 grants from Michael Wyatt
Search grants from Harvard University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Medical Genetics Postdoctoral Fellowship
Informatics Center for Neurogenetics and Neurogenomics - Analysis Core
Role of Commitment in Mental Health
Dendritic Function/Plasticity in the Intact Hippocampus
Structural Medical Image Segmentation
Recently added grants:
Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology
Neutrophil plasticity in autoimmune disease
Enhance Arthroplasty Research through Electronic Health Records and Nlp-Enabled Informatics
H. pylori-induced Inflammation and Gastric Cancer
Understanding the mechanism of action for anticancer sulfonamides that target splicing
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32CA073135-01
Application #
2011167
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1997-08-25
Project End
Budget Start
1997-03-04
Budget End
1998-03-03
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Harvard University
Department
Other Basic Sciences
Type
Schools of Public Health
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1998
F32 CA
Human 3-Mea DNA Glycosylase and Alkylation Repair
Wyatt, Michael D. / Harvard University
NIH 1997
F32 CA
Human 3-Mea DNA Glycosylase and Alkylation Repair
Wyatt, Michael D. / Harvard University
Publications
Allan, J M; Engelward, B P; Dreslin, A J et al.
(1998)
Mammalian 3-methyladenine DNA glycosylase protects against the toxicity and clastogenicity of certain chemotherapeutic DNA cross-linking agents.
Cancer Res 58:3965-73
Comments
Be the first to comment on Michael Wyatt's grant